Periodate-oxidized ATP stimulates the permeability transition of rat liver mitochondria  by Henke, Wolfgang et al.
 .Biochimica et Biophysica Acta 1363 1998 209–216
Periodate-oxidized ATP stimulates the permeability transition of rat liver
mitochondria
Wolfgang Henke ), Thilo Hagen, Klaus Jung, Stefan A. Loening
Research Di˝ision, Department of Urology, Uni˝ersity Hospital Charite, Humboldt Uni˝ersity, Schumannstraße 20r21, D-10098 Berlin,´
Germany
Received 21 November 1997; accepted 11 December 1997
Abstract
 .  .Periodate-oxidized ADP oADP and periodate-oxidized ATP oATP stimulate the permeability transition in energized
rat liver mitochondria measured as the Ca2q-efflux induced by Ca2q and P . In the presence of Mg2q and P , mitochondriai i
lose intra-mitochondrial adenine nucleotides at a slow rate. oATP induces a strong decrease of the matrix adenine
nucleotides which is inhibited by carboxyatractyloside. Under these conditions, Mg2q prevents the opening of the
permeability transition pore. EGTA prevents the P -induced slow efflux of adenine nucleotides, but is without effect on thei
oATP-induced strong decrease of adenine nucleotides. This oATP-induced strong adenine nucleotide efflux is inhibited by
ADP. oATP reduces the increase of matrix adenine nucleotides occurring when the mitochondria are incubated with Mg2q
and ATP. This effect of oATP is also prevented by carboxyatractyloside. oATP is not taken up by the mitochondria. It is
suggested that oATP induces a strong efflux of matrix adenine nucleotides by the interaction with the ADPrATP carrier
from the cytosolic side. The induction of the mitochondrial permeability transition by oADP and oATP is attributed to two
mechanisms—a strong decrease in the intramitochondrial adenine nucleotide content, especially that of ADP, and a
stabilization of the c-conformation of the ADPrATP carrier. q 1998 Elsevier Science B.V.
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1. Introduction
The accumulation of Ca2q and P by mitochondriai
leads to a marked permeability transition of the inner
Abbreviations: oAMP, periodate-oxidized AMP; oADP, peri-
odate-oxidized ADP; oATP, periodate-oxidized ATP; PTP, per-
meability transition pore
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membrane. The discovery that the permeability tran-
sition can be inhibited by the immuno-suppressive
agent cyclosporin A initiated decisive investigations
to discriminate between two hypothesis—an increase
of the inner membrane permeability by unspecific
w xchanges or by specific pore opening 1 . Increased
permeability is now attributed to the opening of a
 .so-called permeability transition pore PTP . The
molecular identity and function of the pore are at
present a matter of discussion. Effectors of PTP
opening and closure are among others Ca2q, Mg2q,
P , ADP, reactive oxygen species and polyamines.i
0005-2728r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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There is growing evidence that PTP opening is in-
w x w xvolved in apoptosis 2,3 and ischemic injury 4,5 .
X X  .The 2 ,3 -dialdehyde derivative of ATP oATP ,
w xprepared by periodate oxidation of ATP 6 , was used
in various studies in order to investigate the active
site of ATP-dependent enzymes such as pyruvate
w x q w x 2qcarboxylase 6 , H -ATPase 7 and Ca -ATPase
w x8 . oATP is particularly appropriate for covalent-lin-
kage studies because the reactive moiety is the modi-
w xfied ribose which can only link to the binding site 8 .
Surprisingly, preliminary studies with isolated liver
mitochondria have demonstrated that oADP and oATP
w xstimulate, in contrast to ADP and ATP 9 , the open-
ing of the PTP. Both ADP and ATP inhibit the
permeability transition, but the view prevailed that
ADP is the only relevant nucleotide. It is generally
assumed that ADP affects the permeability transition
w xfrom the matrix side 10 .
The purpose of this study is to investigate whether
the periodate-oxidized derivatives of ADP and ATP
directly interact with the pore-forming protein and,
therefore, might be used for affinity labeling studies.
The permeability transition was measured as the Ca2q
efflux induced by Ca2q and P . This is a well-estab-i
wlished approach to investigate the pore opening 10–
x12 .
2. Materials and methods
2.1. Materials
Periodate-oxidized derivatives of AMP, ADP and
ATP, purine compounds, used as standards for HPLC
analysis, and arsenazo III were purchased from Sigma
 .Deisenhofen, Germany and carboxyatractyloside
 .from Boehringer Mannheim Mannheim, Germany .
All other chemicals were of highest purity commer-
cially available.
2.2. Isolation of mitochondria
Fed adult male Wistar rats weighing 200–250 g
were used. The isolation of liver mitochondria was
w xperformed by differential centrifugation 13 , apply-
ing a solution of 210 mM mannitol, 70 mM sucrose,
 .10 mM Tris–HCl pH 7.4 , and 0.5 mM EDTA. The
mitochondrial pellet was washed twice. For the sec-
ond washing step, EDTA was omitted. Finally, the
mitochondria were resuspended in the isolation
medium without EDTA. The protein content was
determined by the Biuret method with bovine serum
w xalbumin as the standard 13 .
2.3. Adenine nucleotide efflux and net uptake
The mitochondria were incubated at 308C in the
resuspension medium containing 2 mM KH PO , 52 4
mM MgCl and 5 mM glutamate and malate. This2
solution was used as the standard incubation medium.
After indicated time periods, the mitochondria were
centrifuged at 48C and washed once. The final pellet
was resuspended in the isolation medium at a protein
content of about 4 mgrml. Adenine nucleotides were
extracted with perchloric acid and determined enzy-
w xmatically as described 14 .
2.4. Ca2q-efflux measurements
The mitochondria were preincubated in the resus-
pension medium, containing Ca2q, oADP or oATP as
well as 5 mM glutamate and malate, at a protein
content of about 1.5 mgrml at 378C for 1 min. The
Ca2q-efflux was induced with 2 mM KH PO and2 4
traced with 50 mM arsenazo III at 650 nm and 690
nm using the microplate reader HT III and the
EIArKIN-Star software, version 7.0 Anthos Labtec
.Instruments, Salzburg, Austria .
2.5. Dissociation constants of the Ca2q-complexes of
arsenazo III and oATP
The dissociation constant of the Ca2q–arsenazo III
complex was determined by titrating arsenazo III 0
. 2q to 0.1 mM with several Ca concentrations 0 to
. 2q0.5 mM and that of the Ca –ATP complex by
2q titrating 0.05 mM arsenazo III plus Ca 0.01 to 0.1
.  .mM with oATP 0.05 to 2 mM . The calculation of
the dissociation constants is based on the conserva-
tion equations of the total concentrations of arsenazo
III, Ca2q and oATP and accounts for the fact that
arsenazo III and the Ca2q–arsenazo III complex con-
tribute to the absorption with different extinction
w xcoefficients 15 . Applying a nonlinear regression
w xprocedure 16 , extended by an iterative algorithm to
compute the concentration of the different species
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w xinvolved in the complex formation 17 , the dissocia-
tion constants of the Ca2q–arsenazo III complex and
Ca2q–oATP complex are estimated to be 10.5 mM
and 128 mM, respectively.
2.6. Uptake studies with periodate-oxidized ATP
The uptake of oATP was investigated by an HPLC
w xmethod 18 . A 1090M HPLC system with diode
 .array detector Hewlett Packard, Vienna, Austria and
a narrow-bore column, 100 mm=2 mm I.D., with an
integrated guard column, 7 mm = 2 mm I.D.,
 .Knauer, Berlin, Germany filled with ODS Hypersil
 .Shandon, UK were applied. The mobile phase A
 .consisted of 10 mM NH H PO pH 5 and 2 mM4 2 4
tetrabutylammonium bromide and the mobile phase B
 .contained 10 mM NH H PO pH 6.5 , 0.5 mM4 2 4
 .tetrabutylammonium bromide and 25% vrv aceto-
nitrile. The gradient elution started with 10% of
mobile phase B, increased linearly to 80% during 35
min and continued for 10 min.
3. Results
3.1. Stimulation of the permeability transition by
oADP and oATP
ADP inhibits the Ca2q- and P -induced Ca2q-ef-i
flux. In contrast, oADP leads to a stimulation of the
Fig. 1. Stimulation of Ca2q-efflux by periodate-oxidized ADP.
Mitochondria were incubated with 60 mM Ca2q as described in
 . 2qSection 2 ’ . The Ca -efflux was induced with 2 mM P .i
 .  .Further additions: oADP—100 mM I , 500 mM = ; ADP—1
 .  .mM B , 10 mM q . Results are representative of three
independent experiments including the application of different
Ca2q concentrations.
Fig. 2. Stimulation of Ca2-efflux by periodate-oxidized ATP.
Mitochondria were incubated with 60 mM Ca2q as in Fig. 1. The
 .following oATP concentrations were applied: 0 mM B , 0.05
 .  .  .  .mM q , 0.25 mM I , 0.5 mM = , 1 mM ’ . The concen-
2q  . 2qtration of the Ca –arsenazo III complex A and the total Ca
 .in the medium B was calculated as described in Section 2.
Results are representative of three independent experiments in-
cluding the application of different Ca2q concentrations.
2q  .Ca -efflux Fig. 1 . oATP, like oADP, stimulates
 .the permeability transition Fig. 2B . In the presence
of oATP, the absorption of the Ca2q–arsenazo III
complex reached at maximal Ca2q-efflux is depressed
 .with increasing oATP concentrations Fig. 2A . This
effect is caused by the complexation of extramito-
chondrial Ca2q by oATP as proven by calculating the
total Ca2q-concentrations appearing in the medium
 .Fig. 2B . oAMP has no significant effect on the
2q 2q  .Ca -efflux induced by Ca and P not shown .i
3.2. oATP-induced changes in the matrix adenine
nucleotide content
The matrix adenine nucleotide content of liver
mitochondria incubated in the presence of 2 mM Pi
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Fig. 3. Stimulation of adenine nucleotide efflux by oATP. Changes
 .in the matrix adenine nucleotide AdN content in rat liver
mitochondria were measured as described under Section 2 with
 .  .the following additions: 0 mM oATP I , 0.5 mM oATP ‘
 .and 0.5 mM oATP and 15 mM carboxyatractyloside v . Mean
"S.D., ns3.
2q  .and 5 mM Mg decreases at a slow rate Fig. 3 .
This adenine nucleotide efflux is carboxyatractylo-
side-insensitive and, therefore, attributed to the
2q w xMg ATPrP carrier 19 . oATP strongly acceleratesi
the decrease in the intramitochondrial adenine nu-
 .cleotide content Fig. 3 . Five minutes after the addi-
tion of 0.5 mM oATP, the shortest time investigated,
the adenine nucleotide content decreases to about
15% of the initial value. The oATP-induced adenine
Fig. 4. Inhibition of the oATP-stimulated adenine nucleotide
efflux by ADP. Incubations of the mitochondria were performed
 .in the presence of 2 mM EGTA. Additions: 2 mM ADP I ; 0.2
 .mM oATP and the following ADP concentrations—0 mM ‘ ,
 .  .  .0.2 mM B , 0.5 mM ’ or 2 mM v . Mean"S.D., ns3.
nucleotide efflux is inhibited by carboxyatractyloside
to the level of the carboxyatractyloside-insensitive
efflux in the absence of oATP.
EGTA inhibits the adenine nucleotide efflux oc-
 .curring in the presence of P Fig. 4 . This effect ofi
EGTA is caused by complexation of endogenous
Ca2q and illustrates the known fact that Ca2q stimu-
2q w xlates the efflux rate of the Mg ATPrP carrier 19 .i
In the presence of EGTA, oATP also induces a rapid
decrease of matrix adenine nucleotides. ADP inhibits
 .this oATP-induced efflux Fig. 4 .
In mitochondria incubated in the presence of 4
mM ATP, 5 mM Mg2q and 2 mM P , the matrixi
adenine nucleotide content increases over time. This
net uptake of adenine nucleotides is carboxyatractylo-
 .side-insensitive Fig. 5 and occurs via the
2q w xMg ATPrP carrier 19 . The increase in the intra-i
mitochondrial adenine nucleotide level is reduced by
oATP. Carboxyatractyloside restores the increase of
matrix adenine nucleotides inhibited by oATP to the
 .rate measured without oATP Fig. 5 .
The observed effect of oATP on the matrix ade-
nine nucleotide content is not caused by the induction
of the permeability transition, which has been found
Fig. 5. Effect of oATP on Mg2qATP net uptake. Mg2qATP net
uptake was measured with 4 mM ATP and 5 mM Mg2q using
 .the incubation medium and no additions I , 15 mM carboxya-
 .  .tractyloside B , 4 mM oATP ‘ , or 4 mM oATP and 15 mM
 .carboxyatractyloside v . In experiments investigating the effect
of oATP, the Mg2q concentration was increased from 5 mM to 9
mM. This change accounts for the formation of the Mg2q –oATP
complex and keeps the concentration of Mg2qATP constant. In
 .comparison with no additions, the effect of 4 mM oATP ‘ is
 .statistically significant P -0.01 . Mean"S.D., ns3.
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Fig. 6. Prevention of the oATP-stimulated Ca2q-efflux by Mg2q.
Mitochondria were incubated with 5 mM Mg2q and 0.5 mM
2q  .oATP applying the following Ca concentrations: 0 mM B ,
 .  .  .40 mM ’ , 60 mM ) and 80 mM I .
to lead to a depletion of adenine nucleotides in
w x 2qmitochondria 20,21 . Without the addition of Ca
and in the presence of 2 mM P , 5 mM Mg2q and 0.5i
mM oATP, no permeability increase in energized
 .mitochondria was observed Fig. 6 . The mitochon-
dria incubated under these conditions, however, are
able to perform the permeability transition when Ca2q
is added.
3.3. Uptake studies with periodate-oxidized ATP
The effect of carboxyatractyloside on both the
oATP-induced efflux of matrix adenine nucleotides
and the oATP-inhibited increase of matrix adenine
nucleotides of mitochondria incubated with
Mg2qATP leads to the assumption that the externally
added oATP exerts its effect via the ADPrATP
carrier. The ADPrATP carrier exchanges extramito-
chondrial versus intramitochondrial ADPrATP by a
w xone-for-one mechanism 22 . If the oATP-induced
efflux of adenine nucleotides occurs by the same
mechanism it should be paralleled by an equimolar
accumulation of oATP in the matrix. To measure the
oATP taken up by mitochondria we applied an HPLC
method. Since oATP is hydrolysed by the F1-ATPase
w xof beef heart mitochondria 23 we also included
oAMP and oADP in the standard mixture of purine
Fig. 7. Uptake studies with periodate-oxidized ATP. Mitochondria were incubated with 0.5 mM oATP in the standard incubation medium.
 .HPLC chromatograms of purine derivatives standards A and of neutralized perchloric acids extracts of mitochondria without incubation
 .  .  .B and after incubation without C and with 0.5 mM oATP for 15 min D . Symbols: Ino—inosine, Ado—adenosine, AMP—adenosine
5X-monophosphate, ADP—adenosine 5X-diphosphate, ATP— adenosine 5X-triphosphate, GDP—guanosine 5X-diphosphate, GTP—guano-
sine 5X-triphosphate.
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derivatives used for the HPLC analysis. Rat liver
mitochondria incubated with oATP did not contain
oATP, oADP or oAMP. The content of adenine
nucleotides was more decreased in mitochondria in-
 .cubated with oATP than without oATP Fig. 7 .
4. Discussion
Periodate-oxidized ATP induces a rapid decrease
in the adenine nucleotide content of isolated liver
mitochondria. In principle, a decrease in the matrix
adenine nucleotide content may be attributed to the
intramitochondrial catabolism of purine nucleotides
and the efflux of adenine nucleotides either after the
opening of the PTP or via the Mg2qATPrP carrier.i
Recently, several reports described that rat liver
mitochondria are equipped with enzymes catabolizing
w xintramitochondrial adenine nucleotides 24–27 . The
catabolism of matrix adenine nucleotides is favored
under deenergized conditions and not influenced by
w xcarboxyatractyloside 25 . Since the oATP-induced
adenine nucleotide efflux was investigated at ener-
gized conditions and an inhibition of the oATP effect
by carboxyatractyloside was observed, we conclude
that the catabolism of matrix adenine nucleotides is
not involved.
Opening of the PTP can be ruled out as the
mechanism for the oATP-induced decrease of matrix
adenine nucleotides since Mg2q was present in the
net transport experiments. Mg2q is a powerful in-
w xhibitor of the PTP opening 28–30 and also prevents
any permeability increase in the presence of oATP
and P if no Ca2q is added.i
w x 2qLiver mitochondria 19 translocate Mg ATP
from the cytosol to the matrix and vice versa. The
transport of Mg2qATP proceeds as an antiport with
P . Micromolar Ca2q-concentrations stimulate thei
transport rate. The Mg2qATPrP carrier is involvedi
in the regulation of the matrix adenine nucleotide
w xcontent 31 . oATP strongly accelerates the adenine
nucleotide net loss and diminishes the net accumula-
tion of adenine nucleotides measured at conditions
often applied to characterize the Mg2qATPrP car-i
w xrier 31 . The two effects of oATP on net transport
are prevented in the presence of carboxyatractyloside.
Since the Mg2qATPrP carrier is insensitive to car-i
w xboxyatractyloside 19 and carboxyatractyloside af-
w xfects specifically the ADPrATP carrier 22 , we con-
clude that the effects of oATP on the adenine nu-
cleotide content are not mediated by the
Mg2qATPrPi carrier. This conclusion is supported
by the finding that ADP inhibits the oATP-induced
adenine nucleotide efflux observed at conditions
eliminating the activity of the Mg2qATPrP carrier.i
ADP is a high affinity substrate for the ADPrATP
w x 2qcarrier 22 and a poor substrate for the Mg ATPrPi
w xcarrier 31 . Therefore, the observed inhibition sug-
gests a competition of ADP and oATP at the cytoso-
lic adenine nucleotide binding site of the ADPrATP
carrier.
Summarizing the data, it is suggested that oATP
decreases the matrix content of adenine nucleotides
through an interaction with the ADPrATP carrier.
Since mitochondria incubated with oATP did not
contain oATP, oAMP or oADP, the decrease in the
matrix adenine nucleotide content cannot be due to a
one-for-one exchange of oATP against intramito-
chondrial ADP or ATP. It is generally assumed that
the dimeric ADPrATP carrier possesses one adenine
w xnucleotide binding site 22 . However, there are sev-
eral results indicating at least two binding sites.
Sequential models of the ADPrATP carrier with
simultaneous occupation by ATP and ADP of both an
inner and outer nucleotide binding sites have been
w xproposed 32–36 . Presumably, the reaction of oATP
with the adenine nucleotide binding site facing the
cytosolic side eliminates the one-for-one exchange
mode normally inherent to the ADPrATP carrier
function. The effect of oATP on liver mitochondria is
similar to that of P in heart mitochondria. Here, Pi i
induces a carboxyatractyloside-sensitive efflux of ma-
trix adenine nucleotides which occurs via the
w xADPrATP carrier 37 .
Both oADP and oATP, in contrast to their parent
compounds, stimulate the Ca2q-efflux induced by P .i
The induction of the mitochondrial permeability tran-
sition by oADP and oATP could be brought about by
two mechanisms, through a pronounced decrease in
the intramitochondrial adenine nucleotide content and
through a direct interaction with the ADPrATP car-
rier. The first hypothesis is in accordance with results
showing increased rates of swelling in mitochondria
depleted of adenine nucleotides by pretreatment with
w xpyrophos-phate 10 . oATP induces a rapid decrease
of matrix adenine nucleotides within 5 min. In this
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time range, both the adenine nucleotide content is
reduced to about 15% of its initial level and the
Ca2q-efflux induced by P increases abruptly. Thei
overall loss of adenine nucleotides diminishes the
matrix content of ADP. Since intramitochondrial ADP
is an effective inhibitor of the PTP opening
w x9,10,38,39 the loss of adenine nucleotides is sug-
gested to stimulate the opening of the PTP. The
second hypothesis is supported by the fact that the
ADPrATP carrier has been considered a likely can-
w xdidate as the pore-forming protein 36,40 . Recently
published data lead to the view that the conforma-
tional state of the ADPrATP carrier influences the
w xpore-forming protein 1,29,41 . The binding of car-
boxyatractyloside to the ADPrATP carrier, occurring
only from the cytosolic side and stabilizing the corre-
sponding carrier orientation, termed c-conformation
w x w x36 , induces the opening of the PTP 36,40,42 . As
shown by HPLC analysis, oATP is not taken up by
mitochondria. Therefore, we conclude that the perio-
date-oxidized analogues mediate their effects from
the cytosolic side of the mitochondria. It has been
w3 xshown that H oADP reacts with heart mitochondria.
This reaction is partially inhibited by carboxyatracty-
loside and, therefore, attributed to the covalent modi-
w xfication of the ADPrATP carrier 43 . Since oATP
induces a carboxyatractyloside-sensitive loss of ma-
trix adenine nucleotides by the interaction with the
ADPrATP carrier, the stabilization of the carrier in
the c-conformation caused by the binding of oATP
may also promote the pore-opening.
In summary, it is suggested that oADP and oATP
stimulate the mitochondrial permeability transition by
decreasing the intramitochondrial adenine nucleotide
content, especially that of ADP, via the ADPrATP
carrier and by interacting with this carrier from the
cytosolic side.
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